TTRX 주가 차트
TTRX 재무
Turn Therapeutics Inc
$7.12
3.94%
$0.27
종가: Jul 02, 16:00:00 GMT-4
$7.12
0%
$0
애프터마켓: Jul 02, 20:00:00 GMT-4
뒤로
Turn Therapeutics Inc (TTRX) 재무
수입
자산 및 부채 명세서
현금 흐름
연간
분기별
TTRX 소득
미화 수백만 달러. 회계 연도는 2월부터 1월까지입니다.
Follow-Up Questions
Turn Therapeutics Inc의 주요 재무제표는 무엇인가요?
TTRX의 주요 재무 비율은 무엇인가요?
Turn Therapeutics Inc의 매출은 부문 또는 지역별로 어떻게 나뉘나요?
Turn Therapeutics Inc은 수익성이 있나요?
Turn Therapeutics Inc에 부채가 있나요?
Turn Therapeutics Inc의 발행 주식은 몇 주인가요?
주요 통계
이전 종가
$6.85
시가
$6.94
일일 범위
$6.83 - $7.32
52주 범위
$2.57 - $26.5
거래량
20.5K
평균 거래량
32.6K
배당수익률
--
EPS(TTM)
-0.13
시가총액
$212.1M
TTRX란 무엇인가요?
Turn Therapeutics, Inc. is a pharmaceutical and medical device development company. The company is headquartered in Westlake Village, California. The company went IPO on 2025-10-08. Its patented mixing process-commercially referred to as PermaFusion-enables stable suspension of polar, water-soluble active pharmaceutical ingredients (APIs) in oil-based carriers without the use of emulsifiers. Its primary development programs focus on dermatological diseases, including moderate to severe eczema and onychomycosis. Its products and programs include GX-03/Hexagen for Wounds (Hexagen (K160872)), GX-03/Hexagen for Derm (AtopX (K171191)), Sterile Gauze Impregnated with GX-03/Hexagen (XEAL (K183681)), Sterile Collagen/Hexagen Powder (FleX Product), GX-03/Hexagen for Moderate-Severe Eczema, and GX-03/Hexagen for Onychomycosis. GX-03/Hexagen for Wounds (Hexagen (K160872)) is a medical device for treating wounds and burns. GX-03/Hexagen for Derm (AtopX (K171191)) is a medical device for managing dermatitis.
